A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy And Safety Of Intravenous Prasinezumab In Participants With Early Parkinson’s Disease (BN44715 (PARAISO))

Principal Investigator

Dr George Tofaris

Contact us

Email: dendron@ouh.nhs.uk

IRAS number

1012797